CoChat

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

Open access
Falzon, D., Jaramillo, E., Schünemann, H.J., Arentz, M., Bauer, M., Bayona, J., Blanc, L., Caminero, J.A., Daley, C.L., Duncombe, C., Fitzpatrick, C., Gebhard, A., Getahun, H., Henkens, M., Holtz, T.H., Keravec, J., Keshavjee, S., Khan, A.J., Kulier, R., Leimane, V., Lienhardt, C., Lu, C., Mariandyshev, A., Migliori, G.B., Mirzayev, F., Mitnick, C.D., Nunn, P., Nwagboniwe, G., Oxlade, O., Palmero, D., Pavlinac, P., Quelapio, M.I., Raviglione, M.C., Rich, M.L., Royce, S., Rüsch-Gerdes, S., Salakaia, A., Sarin, R., Sculier, D., Varaine, F., Vitoria, M., Walson, J.L., Wares, F., Weyer, K., White, R.A., Zignol, M. · 2011 · European Respiratory Journal
Cited by 1,100

The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.

Abstract

The production of guidelines for the management of drug-resistant tuberculosis (TB) fits the mandate of the World Health Organization (WHO) to support countries in the reinforcement of patient care. WHO commissioned external reviews to summarise evidence on priority questions regarding case-finding, treatment regimens for multidrug-resistant TB (MDR-TB), monitoring the response to MDR-TB treatment, and models of care. A multidisciplinary expert panel used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to develop recommendations. The recommendations support the wider use of rapid drug susceptibility testing for isoniazid and rifampicin or rifampicin alone using molecular techniques. Monitoring by sputum culture is important for early detection of failure during treatment. Regimens lasting ≥20 months and containing pyrazinamide, a fluoroquinolone, a second-line injectable drug, ethionamide (or prothionamide), and either cycloserine or p-aminosalicylic acid are recommended. The guidelines promote the early use of antiretroviral agents for TB patients with HIV on second-line drug regimens. Systems that primarily employ ambulatory models of care are recommended over others based mainly on hospitalisation. Scientific and medical associations should promote the recommendations among practitioners and public health decision makers involved in MDR-TB care. Controlled trials are needed to improve the quality of existing evidence, particularly on the optimal composition and duration of MDR-TB treatment regimens.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1183/09031936.00073611

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 1,100

Metadata

Authors
Falzon, D., Jaramillo, E., Schünemann, H. J., Arentz, M., Bauer, M., Bayona, J., Blanc, L., Caminero, J. A., Daley, C. L., Duncombe, C., Fitzpatrick, C., Gebhard, A., Getahun, H., Henkens, M., Holtz, T. H., Keravec, J., Keshavjee, S., Khan, A. J., Kulier, R., Leimane, V., Lienhardt, C., Lu, C., Mariandyshev, A., Migliori, G. B., Mirzayev, F., Mitnick, C. D., Nunn, P., Nwagboniwe, G., Oxlade, O., Palmero, D., Pavlinac, P., Quelapio, M. I., Raviglione, M. C., Rich, M. L., Royce, S., Rüsch-Gerdes, S., Salakaia, A., Sarin, R., Sculier, D., Varaine, F., Vitoria, M., Walson, J. L., Wares, F., Weyer, K., White, R. A., & Zignol, M.
Venue
European Respiratory Journal
Published
2011-08-02
Volume
38
Issue
3
Pages
516-528
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W2135027892
Cited by
1,100
References
89
FWCI
78.88
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.